Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EORTC H9 Trial in Early-Stage Hodgkin's Lymphoma
NCT00005584Phase 3Active, not recruiting
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 1998
- Primary completion
- May 2004
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of bleomycin + dacarbazine + doxorubicin + vinblastine, BEACOPP, epirubicin in Hodgkin lymphoma (HL), sponsored by European Organisation for Research and Treatment of Cancer. Started Oct 1998; status: active, not recruiting.
02
Drugs
bleomycin + dacarbazine + doxorubicin + vinblastineBEACOPPepirubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00005584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005584.